The authors evaluate the results of argon laser therapy of extrafoveal and juxtafoveal subretinal neovascular membranes in the wet form of age-related macular degeneration. Their experience is evaluated in the group of 24 eyes of 23 patients during the period of observation lasting from 6 to 42 months. It became obvious that in the group of 24 eyes with extrafoveal and juxtafoveal subretinal neovascular membrane the laser photocoagulation cured up the condition in 17eyes (71 %), whereas the therapy failed in 7 eyes (29 %). Vision improved in 7 eyes (29 %), retained stabilized in 10 eyes (42 %), but deteriorated in 7 eyes (29 %). Among 11 eyes with extrafoveal subretinal neovascular membrane the authors reached improvement in 10 eyes (90.9 %), the therapy failed with one eye (9.1%), the vision improved in 6 eyes (55 %), remained stabilized in 4 eyes (36%), but deteriorated in one eye (9 %). In 13 eyes with juxtafoveal subretinal neovascularmembrane 7 eyes were cured up (54 %), the therapy failed in 6 eyes (46 %), vision improved in one eye (8 %), remained stabilized in 6 eyes (46 %), but deteriorated in 6 eyes (46 %). Based on the results obtained it has become obvious that laser photocoagulation is a useful method for the therapy of extrafoveal and juxtafoveal subretinalnaovascular membranes in the age-related macular degeneration. Better prognosis has been shown in the extrafoveal subretinal neovascular membrane.

        Key words: argon laser, age-related macular degeneration